UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
 
 
FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934.
 
Date of Report:  June 1, 2012
(Date of earliest event reported)
 
MRI INTERVENTIONS, INC.
(Exact name of registrant as specified in its charter)
 
Delaware 000-54575 58-2394628
(State or other jurisdiction (Commission File (I.R.S. Employer
of incorporation or organization) Number) Identification No.)
     
One Commerce Square, Suite 2550
    
Memphis, Tennessee    38103  
(Address of principal executive offices)    (Zip Code) 
 
                                                                                                                                                                                       
(901) 522-9300
(Registrant's telephone number, including area code)
                                                                                                   
Not Applicable
(Former Name or Former Address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

¨  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 
 
 
Item 7.01. Regulation FD Disclosure.
 
On June 1, 2012, MRI Interventions, Inc. (the “Company”) issued a press release announcing that it will be exhibiting its ClearPoint® Neuro Intervention System at the American Society for Stereotactic and Functional Neurosurgery Biennial Meeting to be held June 3-6, 2012 in San Francisco, California.  A copy of the press release is furnished herewith as Exhibit 99.1.
 
 
Item 9.01.  Financial Statements and Exhibits.
 
  (d) Exhibits.
     
    See Exhibit Index immediately following signature page.
 
 
2
 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
MRI INTERVENTIONS, INC.
  
     
       
 
By:
/s/ Oscar L. Thomas  
    Oscar L. Thomas  
    Vice President, Business Affairs  
       
       
Date:           June 1, 2012      
 
 
3
 

EXHIBIT INDEX
 
Exhibit No. Description  
     
99.1 Press Release of the Company dated June 1, 2012  
 
 
 
4